SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 25th, 2008 • Verenium Corp • Services-commercial physical & biological research • New York
Contract Type FiledFebruary 25th, 2008 Company Industry JurisdictionSECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 22, 2008, by and among Verenium Corporation, a Delaware corporation, with its principal executive office located at 55 Cambridge Parkway, Cambridge, MA 02142 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 25th, 2008 • Verenium Corp • Services-commercial physical & biological research • New York
Contract Type FiledFebruary 25th, 2008 Company Industry Jurisdiction• transactions where broker-dealers may agree with the selling securityholders to sell a specified number of such shares at a stipulated price per share;
To: Verenium Corporation 55 Cambridge Parkway Cambridge, MA 02142 Attention: Chief Financial Officer From: Capital Ventures International By: Heights Capital Management, Inc., Its Authorized Agent 101 California Street, Suite 3250 San Francisco, CA...Lower Call Option Transaction • February 25th, 2008 • Verenium Corp • Services-commercial physical & biological research • New York
Contract Type FiledFebruary 25th, 2008 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Transaction entered into between Capital Ventures International (“Party A”) and Verenium Corporation (“Party B”) on the Trade Date specified below (the “Transaction”). This Confirmation constitutes a “Confirmation” as referred to in the Agreement specified below.
SENIOR NOTES EXCHANGE AGREEMENTSenior Notes Exchange Agreement • February 25th, 2008 • Verenium Corp • Services-commercial physical & biological research • New York
Contract Type FiledFebruary 25th, 2008 Company Industry JurisdictionThis Senior Notes Exchange Agreement (the “Agreement”) is entered into as of the 22nd day of February, 2008, by and among Verenium Corporation, a Delaware corporation (“Verenium”), and each of the holders listed on the schedules hereto (each a “Holder” and, collectively, the “Holders”), with reference to the following facts: